[1]
Nawaiseh, I. et al. 2017. Intravitreal ranibizumab in the management of acute central serous Chorioretinopathy. International Journal of Clinical and Experimental Ophthalmology. 1, 1 (Nov. 2017), 049–054. DOI:https://doi.org/10.29328/journal.hceo.1001007.